The government has agreed to drop its appeal of a D.C. federal district court decision permitting the use of copay accumulator adjustment programs to help patients pay for their medicines.
The Justice Department on Tuesday moved to withdraw its appeal of a recent decision by the US District Court for the District of Columbia in a case brought by the HIV & Hepatitis Policy Institute, overturning a Trump administration rule that allowed health insurers to avoid counting drug manufacturer copay assistance towards beneficiaries’ annual limits on deductible and out-of-pocket costs.
The government’s action came after 19 senators sent a letter ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.